What Sally Mueller learned from a short doctor visit about menopause

A small white bottle that lists plant ingredients but not their farms opens this account. The Supplement Facts panel for Me.No.Pause. gives a daily serving, while the origin of each botanical lot stays inside company files.

Sally Mueller arrived with joint aches, parched skin and vaginal dryness and left with one word that joined them together. Her clinician said menopause, a term she had not applied to herself until that appointment. She repeated the story to Michelle Jacobs on a long delayed catchup between two colleagues who first met twenty years earlier at the start of their brand careers.

Jacobs had shaped labels for Polo Ralph Lauren and Lancome, spent time in publishing retail, and worked alongside the Joy Mangano label. Mueller had directed brand launches as a Target marketing executive and as chief brand officer at Cherokee Inc. and Clique Brands. Both women looked for current guidance, peer support and well made goods for this life phase and found little. They therefore started the line they wished had existed.

Womaness began in 2021 with thirteen goods across skincare, body, wellness, sexual health and incontinence, offered on womaness.com and inside Target stores. The company received the 2021 Beacon Award for Best Brand Launch, introduced a sleep capsule called Let Me Sleep that same year, closed a 4 million dollar seed round led by Unilever Ventures and Obvious Ventures in 2022, and moved onto Amazon and QVC, with founders projecting a store count above 1,800 doors through one more chain.

What Half Life watches, and what glossy coverage tends to skip, is dose against proof. Womaness says its goods rely on strong, well studied plant based components, paired with doctor, gynecologist, consumer and allergy testing, and made with no parabens, phthalates, sulphates, estrogen, phytoestrogen or added hormones. One part of that statement can be checked on a label, another part points to trials that shoppers cannot yet read lot by lot. This interview works backward from the swallowed capsule to the harvested plant, asking about milligrams, absorption, persistence and controls.

You launched in 2021 with thirteen products and went directly into Target stores plus your own site. For a new supplement line, what did that early assortment require you to lock in on farms, formulas and fill.

Sally Mueller: Michelle and I had been friends for two decades. We were close companions, joint makers, candid advisers. Then during a catchup I shared what my clinician had explained. That the shifts in my body reflected menopause. I had missed the link. When we asked friends and coworkers, we saw how frequent this blind spot was. There was little plain teaching, backing, or current goods for this period in a woman life. So we acted. We aimed to land the right messages, because our customer is in her 40s, 50s and later, moving through perimenopause, menopause and postmenopause. I believe many women are responding, at last. At last a brand notices this phase and addresses it plainly.

Michelle Jacobs: We phrase it like this. By women, for women. We notice you, we listen to you, we resemble you. We reject the pause. We wish to update aging with fresh answers, useful facts and steady encouragement. Live Fully. Age Well. That required listening first. What the past year showed is that women wish to speak candidly about it. You only need to offer a setting where discussion feels safe.

Thirteen stock keeping units is a broad debut for a team that prizes leanness. What did that width teach you about messaging and the path to purchase?

Sally Mueller: It made us remain very lean because operations shift so sharply across the first six to nine months, and only then do true requirements emerge. We opened with thirteen items across skincare, body care, wellness, sexual health and incontinence. That breadth is wide. You must picture a funnel. Shoppers entering at the top might have noticed the label on tv, or in print, so they come informed, but then how do you guide them stage by stage toward a sale. Our customer still follows legacy outlets. She values consistency. She seeks familiarity, she seeks a fuller narrative.

Michelle Jacobs: I believe much invention follows debut. That period demands real persistence. What your slide deck predicted would succeed does not always succeed. We recognized sexual wellness as a key category, but we did not foresee how strongly it would perform. Post launch listening showed where to invest next, whether in a neck serum with a rollerball or a daily capsule. The range taught us to hold the chain tight enough to allow revision.

Your front label rejects parabens, phthalates, sulphates, estrogen, phytoestrogen and added hormones. What does that boundary mean for the Me.No.Pause. serving on paper?

Sally Mueller: We prefer established botanical components to estrogen or added hormones. That principle was fixed early. Our goods hold no estrogen, phytoestrogen or added hormones and are vegan and gluten free. We read the formula and it leaves out parabens, phthalates and sulphates. For Me.No.Pause., which is our natural, clinically tested and doctor approved capsule for menopause and perimenopause, that choice puts pressure on the Supplement Facts panel. Which botanicals, at which levels, in which chemical form. Which capsule shell and processing aids appear in other ingredients. We favor goods worthy of display, not concealment, yet the panel must remain legible.

Michelle Jacobs: Clean goods built from strong, established, well studied botanical components. That wording matters only when files support it. We cite doctor, gynecologist, consumer and allergy testing. The terms natural, clinically tested and doctor approved sit on Me.No.Pause. because the company uses that language. Viewed for sourcing, the unresolved issue is one we accept. Which cultivator, which crop, which lot. The pack lists components and daily intake. It omits the farm. That remains the stage where shoppers ask for greater transparency.

A capsule in the palm has a fill weight, a shell and a lot code. What paperwork sits behind that code today?

Michelle Jacobs: Start by holding the capsule in the hand. It carries a fill mass, a shell, and a lot identifier linked to a batch. Upstream from that batch lies a powder or extract created through drying and extraction of botanical matter. Further upstream lies a crop from a cultivator. What we can trace lot by lot is the paper trail. The specification per component, the certificate of analysis covering identity and caps for heavy metals and microbes, and independent lab retests where relevant. That is how identity is confirmed. You test the shipment toward the spec, you archive the lot file, you keep the reserve sample.

Sally Mueller: Where precisely it originates, and what evidence confirms it. That query is fair. What we publish now is the recipe, the daily intake, and the testing statement. What we do not yet disclose is the cultivator identity and harvest site for each plant lot on the box. That segment stays hidden from buyers. Greater openness would mean listing growers per component, stating extract type and standardisation if present, and tying the certificate of analysis to the code printed on the jar. We kept staffing light early in order to learn. This is the direction that learning indicates.

You sell on your site, Target, Amazon and QVC, nearing over 1,800 doors with another chain. What does that distribution demand of encapsulation, testing and lot records.

Sally Mueller: It demands rigor. Every retail account sets separate rules for wording, for seals, for adverse event intake, for lot tracking. You must view it as a funnel forward stage by stage to checkout, yet also in reverse through sourcing to field. A single jar on a Target shelf must connect to its batch file. The same applies to Amazon and QVC and our storefront. Memory cannot sustain that. Paper sustains it. Specification, purchase order, inbound lot, certificate of analysis, blending log, encapsulation log, finished assay, reserve sample.

Michelle Jacobs: A lean staff aided this effort. Operations shift so sharply across the first six to nine months. If staff grows before true needs are known, the essential records slip. We trained ourselves to request the sheet behind terms such as pure. When a vendor claims pure, we seek the assay, the heavy metals results, the micro results, the allergen declaration. When they claim natural, we ask for its definition in the spec. That pace is slower, yet it lets a compact group supply many outlets while preserving the link from cultivation to capsule.

Sleepless nights appeared beside hot flashes in your early customer calls. How does Let Me Sleep compare with Me.No.Pause. on sourcing and dose form?

Sally Mueller: Let Me Sleep entered the range in our debut year because broken sleep surfaced in the same reports as hot flashes and dry skin. It is a dietary capsule for sleep, used daily per pack directions. Sourcing mirrors the same sequence. Procured components, dried and made to spec, mixed, filled to target weight, checked by lot. The contrast lies in the component mix and capsule behavior. A night formula can contain separate botanicals and separate aids for flow and packing, so its other ingredients line looks distinct. That is why we advise close readers to study both panels on both jars, not only the front claims.

Michelle Jacobs: Homes purchase in that pattern. For a partner, a parent, themselves. They maintain a compact shelf for years instead of sampling novelty monthly. They have bought the costly option and seek to judge value. So we hold wording consistent. What the good is, how it is taken, what it excludes. No estrogen, phytoestrogen or added hormones throughout. Vegan and gluten free as labeled. Farm identities appear on neither pack at present. The testing claim does. That is the candid divide between what is tracked internally by lot and what a shopper can inspect.

The careful buyer keeps our products for years and deserves to see the field behind the capsule, or to be told exactly why she cannot yet.

Michelle Jacobs

In 2022 you closed a 4 million dollar seed round led by Unilever Ventures and Obvious Ventures. What did outside capital alter about sourcing and testing.

Sally Mueller: Funding allowed planning past the next order. It allowed carrying suitable stock, reordering toward spec instead of toward scarcity, and holding assay practice steady lot to lot. It left the bar unchanged. No parabens, phthalates, sulphates. Strictly no estrogen, phytoestrogen, or added hormones inside. It created space to uphold that bar while we observed sales, identified reformulation needs, and improved procurement. Persistence after debut takes funds. Assaying each lot takes funds. Storing reserve samples takes funds.

Michelle Jacobs: Backers also demand order. Where is the spec. Where is the certificate of analysis for that claim. Which alternate cultivator covers a failed crop. That scrutiny helps. It shifts a company from founder recall to documented method. We aim to strike the right messages, but each message needs a folder. The folder holds the field lot, the extraction log, the lab outcome, the batch connection. Investment gave us time to assemble that folder correctly.

We see you, we hear you, we are you and Live Fully. Age Well. appear in ads, but what do they require from a Supplement Facts panel?

Michelle Jacobs: We see you, we hear you, we are you signals writing for a reader who scrutinizes. She studies the Supplement Facts panel and the other ingredients line. She checks independent seals and understands they differ. So we keep the front plain and the back precise. Me.No.Pause. is stated as daily dietary supplement for menopause and perimenopause. Let Me Sleep is stated as sleep supplement. Directions appear plainly. No claims beyond brand language and pack detail.

Sally Mueller: Live Fully. Age Well. explains our rejection of embarrassment. We prefer display worthy goods to shameful ones. That is why a neck serum carries a cooling rollerball and a body cream bears a direct title like The Works. For capsules, display worthy means a jar left visible without apology, with wording that withstands inquiry. We reject the pause. We accept documentation. Where proof is absent, a claim should not appear.

Where does the trail still break, and what would full field traceability demand in milligrams and paper?

Sally Mueller: What holds today is the finished lot connection. Batch code to mix to component lots to certificates of analysis and to stated testing. What a purchaser still cannot view is the source tier. Cultivator name, harvest site and date, drying approach, extraction solvent and ratio, standardisation goal where applicable. Full traceability would mean releasing that per component, per lot, or at least per recipe version, and tying it to the code on the jar. That effort is real, yet it is straightforward effort.

Michelle Jacobs: It would also demand defining clean with each use. For us clean has signified strong, well studied botanical components, with stated testing, and free of the excluded list. That definition should live in the file, not only in conversation. When a stage stays hidden, name it on the label. Where a seal addresses only the plant and not the goods, disclose it. The attentive buyer retains our goods for years. She merits a view of the field beyond the capsule, or a clear account of why that view is not yet available.

Closing note from the desk

What remains for this desk is a familiar pharmacology gap. The internal chain links batch numbers to specifications and assay sheets with steady discipline. The public pack reports serving size and exclusions but withholds cultivator, harvest timing and solvent detail that would let a reader judge dose and bioavailability. That divide is widespread across botanicals, yet credit is due for stating it openly.

The label set out to update aging for women in their 40s, 50s and later, with jars fit for a visible shelf and files able to support them. The decisive test, in both founders terms, will be printing the harvest behind each lot in numbers a skeptical shopper can verify.

Product spotlight

Me.No.Pause. costs 46.99 dollars as a daily dietary supplement for menopause and perimenopause. The company calls it natural, clinically tested and doctor approved, formulated with no estrogen, phytoestrogen or added hormones. Use as the pack directs and inspect the Supplement Facts plus other ingredients lines for amounts per serving and capsule components.

Let Me Sleep, 26.99 dollars, sleep capsule added in 2021. The company frames it for homes that hold a compact, stable set, for use as directed. Place its Supplement Facts and other ingredients line beside Me.No.Pause. to compare shared processing aids and distinct botanical loads.